(1) Medical Radiology Research Center, Russian Academy of Medical Sciences, Obninsk, Russia;(2) Sechenov Medical Academy, Moscow, Russia;(3) Obninsk State Technical University for Nuclear Power Engineering, Obninsk, Russia;
Abstract:
This review gives a brief outline of the history of development of radiopharmaceuticals (RPh) for radionuclide diagnostics
of bone pathology. The advantages of RPh based on 99mTc-diphosphonates are demonstrated.